Jenny Liu

发表

Particles without a box: brush-first synthesis of photodegradable PEG star polymers under ambient conditions.

Jeremiah A. Johnson, Jenny Liu, A. X. Gao, 2013, Journal of visualized experiments : JoVE.

Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities.

Jeremiah A. Johnson, Matthew R. Golder, M. Shipitsin, 2021, Journal of the American Chemical Society.

Design of BET Inhibitor Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities

Matthew R. Golder, M. Shipitsin, B. Vangamudi, 2020 .

Dual Role for 1,2,4,5-Tetrazines in Polymer Networks: Combining Diels-Alder Reactions and Metal Coordination To Generate Functional Supramolecular Gels.

Jeremiah A. Johnson, N. Holten-Andersen, Ken Kawamoto, 2015, ACS macro letters.

Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity.

J. C. Barnes, Jeremiah A. Johnson, M. Hemann, 2016, Journal of the American Chemical Society.

"Brush-first" method for the parallel synthesis of photocleavable, nitroxide-labeled poly(ethylene glycol) star polymers.

Jeremiah A. Johnson, N. Turro, Yongjun Li, 2012, Journal of the American Chemical Society.

Crossover experiments applied to network formation reactions: improved strategies for counting elastically inactive molecular defects in PEG gels and hyperbranched polymers.

Jeremiah A. Johnson, B. Olsen, D. Díaz Díaz, 2014, Journal of the American Chemical Society.

A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin

Paula T. Hammond, Erik C. Dreaden, Kevin E. Shopsowitz, 2014, Journal of the American Chemical Society.

Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Jeremiah A. Johnson, Matthew R. Golder, M. Shipitsin, 2018, Nature Biomedical Engineering.

Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Jeremiah A. Johnson, Matthew R. Golder, M. Shipitsin, 2018, Nature Biomedical Engineering.

Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity.

J. C. Barnes, Jeremiah A. Johnson, M. Hemann, 2016, Journal of the American Chemical Society.

Particles without a box: brush-first synthesis of photodegradable PEG star polymers under ambient conditions.

Jeremiah A. Johnson, Jenny Liu, A. Gao, 2013, Journal of visualized experiments : JoVE.